1. Non-Small Cell Lung Cancer Resection in Lymphoma Patients
Min P. Kim, MD, Arlene M. Correa, PhD, Stephen G. Swisher, MD, Wayne L. Hofstetter, MD, Reza J. Mehran, MD, David C. Rice, MB, BCh, Garrett L. Walsh, MD, Jeremy Erasmus, MD, Cesar Moran, MD, Ara A. Vaporciyan, MD, Jack A. Roth, MD 
The Annals of Thoracic Surgery 
Volume 90, Issue 1, Pages (July 2010)
DOI: /j.athoracsur
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
The 5-year overall survival rate for the lymphoma group with lung cancer (35%) was significantly lower than that for the nonlymphoma group with lung cancer (67%; p = 0.04).
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
There was no significant difference in lung cancer-specific survival (p = 0.56).
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

4. Fig 3
In the lymphoma group, the 5-year overall survival did not differ significantly between patients with active lymphoma at the time of lung cancer resection (active lymphoma) and patients with a history of lymphoma but no active lymphoma at time of lung cancer resection (history of lymphoma; p = 0.07).
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions